| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |